MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.

Authors:
Nina V Chaika
Nina V Chaika
University of Nebraska Medical Center
United States
Teklab Gebregiworgis
Teklab Gebregiworgis
University of Nebraska-Lincoln
United States
Vinee Purohit
Vinee Purohit
University of Nebraska Medical Center
United States
Prakash Radhakrishnan
Prakash Radhakrishnan
University of Nebraska Medical Center
United States
Xiang Liu
Xiang Liu
Endoscopy Center
Tulsa | United States
Bo Zhang
Bo Zhang
The Second Affiliated Hospital of Dalian Medical University
Dalian Shi | China
Kamiya Mehla
Kamiya Mehla
University of Nebraska Medical Center
United States

Proc Natl Acad Sci U S A 2012 Aug 6;109(34):13787-92. Epub 2012 Aug 6.

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Aberrant glucose metabolism is one of the hallmarks of cancer that facilitates cancer cell survival and proliferation. Here, we demonstrate that MUC1, a large, type I transmembrane protein that is overexpressed in several carcinomas including pancreatic adenocarcinoma, modulates cancer cell metabolism to facilitate growth properties of cancer cells. MUC1 occupies the promoter elements of multiple genes directly involved in glucose metabolism and regulates their expression. Furthermore, MUC1 expression enhances glycolytic activity in pancreatic cancer cells. We also demonstrate that MUC1 expression enhances in vivo glucose uptake and expression of genes involved in glucose uptake and metabolism in orthotopic implantation models of pancreatic cancer. The MUC1 cytoplasmic tail is known to activate multiple signaling pathways through its interactions with several transcription factors/coregulators at the promoter elements of various genes. Our results indicate that MUC1 acts as a modulator of the hypoxic response in pancreatic cancer cells by regulating the expression/stability and activity of hypoxia-inducible factor-1α (HIF-1α). MUC1 physically interacts with HIF-1α and p300 and stabilizes the former at the protein level. By using a ChIP assay, we demonstrate that MUC1 facilitates recruitment of HIF-1α and p300 on glycolytic gene promoters in a hypoxia-dependent manner. Also, by metabolomic studies, we demonstrate that MUC1 regulates multiple metabolite intermediates in the glucose and amino acid metabolic pathways. Thus, our studies indicate that MUC1 acts as a master regulator of the metabolic program and facilitates metabolic alterations in the hypoxic environments that help tumor cells survive and proliferate under such conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1203339109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427054PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
August 2012
22 Reads

Publication Analysis

Top Keywords

demonstrate muc1
16
pancreatic cancer
16
cancer cells
12
muc1
11
glucose metabolism
8
involved glucose
8
cancer
8
muc1 acts
8
muc1 expression
8
glucose uptake
8
cancer cell
8
indicate muc1
8
expression enhances
8
promoter elements
8
hif-1α p300
8
glucose
5
pancreatic
5
metabolism
5
factor-1α hif-1α
4
hypoxia-inducible factor-1α
4

Similar Publications